Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A for the Period Ending May 31, 2020 Jul 27, 2020 05:03PM
Bioasis Announces Stock Option Grants Jul 7, 2020 09:00AM
Bioasis Announces Filing of Its Fourth Quarter and Fiscal Year-End Financial Statements and MD&A Jun 29, 2020 06:15PM
Bioasis Announces Conversion of Debenture Interest Into Equity Jun 24, 2020 03:33PM
Bioasis Announces Analyst Coverage Initiated by Edison Group Jun 17, 2020 04:20PM


Apr 6, 2020 11:08AM  Bioasis Completes Redemption of 15% Unsecured Debentures With Unanimous Debentureholder Approval
Apr 1, 2020 09:15AM Bioasis Announces Shares for Debt Transaction
Mar 4, 2020 05:12PM Bioasis Technologies Announces the Appointment of Dr. May Orfali to the Position of Consultant Chief Medical Officer
Feb 6, 2020 04:10PM Bioasis to Present at the 22nd Annual BIO CEO Investor Conference and the OTC Markets 2020 Virtual Investor Conference
Jan 6, 2020 04:30PM Bioasis to Present at Upcoming Industry Conferences
Dec 5, 2019 04:05PM Bioasis Announces Annual General Meeting Results
Dec 4, 2019 04:05PM Bioasis Appoints Consultant Chief Medical Officer and Nominates Medical Oncology Advisory Board
Nov 27, 2019 04:05PM Bioasis to Host Annual General Meeting Webcast on December 5, 2019
Oct 10, 2017 08:00AM Bioasis Establishes U.S. Presence with Office in Connecticut